These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2688778)

  • 1. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.
    Gossop M; Griffiths P; Bradley B; Strang J
    Br J Psychiatry; 1989 Mar; 154():360-3. PubMed ID: 2688778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.
    Gossop M; Bradley B; Phillips GT
    Addict Behav; 1987; 12(1):1-6. PubMed ID: 3565107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (3):CD003409. PubMed ID: 12917966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (2):CD003409. PubMed ID: 12076479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial.
    Drummond DC; Turkington D; Rahman MZ; Mullin PJ; Jackson P
    Drug Alcohol Depend; 1989 Jan; 23(1):63-71. PubMed ID: 2646089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients.
    Grünberger J; Linzmayer L; Fodor G; Presslich O; Praitner M; Loimer N
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):109-12. PubMed ID: 2149649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Minozzi S; Ali R; Ferri M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003409. PubMed ID: 16034898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Minozzi S; Ferroni E; Ali R; Ferri M
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003409. PubMed ID: 23450540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (1):CD003409. PubMed ID: 11869660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of a Neuro-Stimulator Device vs. methadone in alleviating opiate withdrawal symptoms.
    Elmoghazy E; Johnson BD; Alling FA
    NIDA Res Monogr; 1989; 95():388-9. PubMed ID: 2701306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.